The Analyst Verdict: OptimizeRx In The Eyes Of 6 Experts
The Analyst Verdict: OptimizeRx In The Eyes Of 6 Experts
分析師的看法：6位專家眼中的OptimizeRx
In examining recent analyst actions...Ratings for OptimizeRx (NASDAQ:OPRX) were provided by 6 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
在過去三個月中，由6位分析師提供的OptimizeRx（納斯達克：OPRX）的評級展示了看好和看淡的觀點混合。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
下表總結了他們最近的評級，提供了對過去30天情緒變化的洞察，並與前幾個月進行了比較。
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $8.25, along with a high estimate of $16.00 and a low estimate of $5.00. A 44.26% drop is evident in the current average compared to the previous average price target of $14.80.
分析師提供了更深入的見解，設定了12個月的價格目標，表明平均目標爲8.25美元，最高估計爲16.00美元，最低估計爲5.00美元。目前的平均價格與之前的14.80美元價格目標相比，明顯下降了44.26%。
Deciphering Analyst Ratings: An In-Depth Analysis
分析師評級解讀：深入分析
In examining recent analyst actions...
通過考察最...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間